Stay updated on Lenvatinib and Pembrolizumab in DTC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in DTC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing study sites by state (CA, CO, MA, MI, NY, OH, TX) as part of revision 3.3.3 and removed the individual state Location subsections. The HHS Vulnerability Disclosure link was removed in revision 3.3.2.
    Difference
    0.8%
    Check dated 2025-12-23T20:43:37.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Added a note clarifying that publications are automatically filled from PubMed and may not be about the study. Updated the revision label to v3.3.2, replacing the previous v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T10:43:14.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The government funding lapse notice about NIH operations, previously displayed on the page, has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:53:56.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Two screenshots show only minor layout and timestamp differences. No substantive content changes to core study details (objectives, eligibility criteria, or outcomes) are visible.
    Difference
    0.3%
    Check dated 2025-11-03T20:50:53.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Summary of changes: Deleted the GI/RDI Genetic and Rare Diseases resource for Differentiated thyroid carcinoma and added a government-operating-status notice with a v3.2.0 update.
    Difference
    2%
    Check dated 2025-10-06T04:50:13.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T02:54:46.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.